Our agenda is designed to push you out of your comfort zone. Are you ready to embrace the naughty step?
Pharmageddon USA 2026 - Environmental shift
A meteorite has hit healthcare. The impact has changed everything: the climate, the terrain, the rules of survival.
Pharma, once the dominant species, now finds itself exposed. Those that can’t adapt will fossilise. Those that can will inherit a new world, one richer, faster, more unpredictable but potentially more bountiful than ever before.
Pharmageddon USA 2026 is where the next species gathers to evolve.
Boom! A meteorite is tearing through healthcare, reshaping everything in its path. As the dust settles, we must find our footing in unfamiliar terrain, reading a new landscape, spotting predators, and learning fast enough to adapt before the next shockwave hits.
[Learn]
Pharmageddon is an event that draws innovators from across pharma, no matter the function, the territory or background. We might be different in character, in sentiment, and in expertise, but we’re united by one thing: an understanding that things can be better, that there is a path to a future where patients are prioritised and where pharma is a truly innovative, dynamic force in healthcare. Before we plunge into the specifics, we need to take stock and unify our aims around a shared vision.
[Solve]
If we’re going to adapt in the new environment, we’re going to have to learn to play the innovation game. The rules can’t be taught—you’ll have to work them out for yourself. The temptation will be to go out on your own, dominating the program to hoard the rewards and the credit, but here’s a tip: the only way to break through is to find a way to work together. If you haven’t cracked the key to cross-functional innovation by the end of this session, you never will.
[Learn]
Some of the most disruptive pressure in healthcare is coming from the tech world. Learn from Silicon Valley gurus thinking outside the box to develop new markets with innovative new solutions. From wearable health trackers to digital avatars, gain an insight into where health disruption is taking place and understand where and how pharma can team up with them to disrupt in powerful new ways.
[Learn]
Healthcare isn’t what it was. No longer are we a reactive industry, and no longer are we in control of our markets. In 2026, a new tributary is running into our industry that risks becoming a flood: wellness. Companies that purport unproven solutions are rubbing up against the FDA, and there is a tinge of misinformation about some wellness programs. Nevertheless, there’s no doubting their impact. Learn from representatives of both camps about where we can learn, where we can challenge and what we should avoid altogether.
[Learn]
How do we define success? Our industry is obsessed with benchmarking; we’re constantly comparing ourselves to competitors, desperate to prove that we are at least as good as them, but this is a terrible way to make progress. Learn from leaders who are advancing their initiatives despite the pressure to conform, and understand how success is never built by looking over your shoulder, but from forging a bold new path.
[Learn]
The pharma business model is changing. In the future, we won’t be selling to the same customers we used to. Understand the new paradigm for selling treatments as pharma starts to embrace a B2C model. Learn from the experts about the regulatory challenges that accompany this change and understand what this new market landscape will mean for the future of our treatment solutions and the nature of our product launches.
The environment has changed. The old model has died. Time to adapt into a new species and make the most of the new opportunities.
[Learn]
Pharma isn’t the only industry going through a recruitment crisis, but thinking about the future of our companies certainly means thinking about the future of our workforce. Learn about the challenges that new AI models pose to future recruitment, understand how we attract the right talent into our organisations and consider how we might be forced to rethink legacy roles into something new and ambitious.
[Solve]
We live in a ‘VUCA’ world now. The old instruction manual has been torn up, uncertainty haunts our every move. If we’re to survive in the new environment, we must bake rigidity into our programs, so that even if external factors crumble, we’ll still be standing strong. Work together to create dynamic solutions that stay stable against the tide of change, and maybe save the world while you’re at it.
[Learn]
Pharma has a challenge on its hands that it wasn’t expecting: how do we defend ourselves in a post-science world? When even the White House is doubting our results, it’s getting harder to foster patient trust. Learn how our pitches need to change, how we need to communicate our offerings with new narratives and we can ensure that our value is communicated to patients.
[Solve]
We all want to please our customers, but what if our customers don’t know what they want? In this session, we’ll show you a new idea for innovation: coming up with bold new solutions and waiting for the reactions. Don’t worry about regulatory constraints; park your concerns about practicalities. It’s time to come up with health programs like concept cars: do something whacky and weird, then test your customer’s reaction to it. This is customer leadership; once you know how it works, you’ll ditch your market research programs overnight.
After adaptation comes survival, but survival isn’t enough for patients. Let’s look to the future and consider how our new species can offer genuine options and push healthcare into new frontiers.
Digital twins aren’t just data models, they’re living, breathing avatars of our patients, our processes, and even our own organizations. Imagine a parallel world where every molecule, every trial, every patient journey can be simulated, stress-tested and optimized before it ever touches the real world. Learn how sci-fi is becoming sci-real, and the consequences opportunity it entails.
[Learn]
What happens when drug development takes months, not years, when previously neglected diseases suddenly have cures? In this session, leaders discuss the nature of the new pharma industry when AI programs achieve their promise across every function of our organisation. Understand how we usher in this change faster and learn where to place the right bets to ensure that this change is beneficial to patients.
[Solve]
Pharma ought to be an industry that everyone loves. After all, we dedicate our working lives to saving lives. The trouble is, we’re terrible at reporting our mission and our work. Communicating our value isn’t just the job of specialist PR teams, we should all be able to do it. Work with you peers to design a radical new trust-building mechanisms and campaigns that go beyond PR—programs that reset how people see and value the work we do.
[Solve]
Pharmageddon is a whirlwind event, but it’s not just about a two day high, then back to the real world of pointless meetings and stunted progress. In the final session, we’ll think about how we can bring the legacy of disruption back to our companies, and think about the personal commitments we can make to encourage broad, inter-organizational change.
Email Lucy Osborne at [email protected]
Thanks for being keen to join us in Philadelphia.
Our intention is to have one non-affiliated ‘patient’ for each team taking part.
If you are interested in being one of these, please write to Lucy on [email protected].
We also have a limited number of spaces for HCPs, media and others. Please write to Lucy on [email protected] if eager to take part.
